Siegfried Holding Past Earnings Performance
Past criteria checks 2/6
Siegfried Holding has been growing earnings at an average annual rate of 25.2%, while the Life Sciences industry saw earnings growing at 19.5% annually. Revenues have been growing at an average rate of 11.8% per year. Siegfried Holding's return on equity is 13.4%, and it has net margins of 8.9%.
Key information
25.2%
Earnings growth rate
24.7%
EPS growth rate
| Life Sciences Industry Growth | 17.6% |
| Revenue growth rate | 11.8% |
| Return on equity | 13.4% |
| Net Margin | 8.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Siegfried Holding AG's (VTX:SFZN) CEO Compensation Looks Acceptable To Us And Here's Why
Apr 12
Does Siegfried Holding (VTX:SFZN) Have A Healthy Balance Sheet?
Mar 15Earnings Miss: Siegfried Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts
Feb 23Siegfried Holding AG's (VTX:SFZN) Business Is Yet to Catch Up With Its Share Price
Jan 27Is Siegfried Holding AG (VTX:SFZN) Worth CHF840 Based On Its Intrinsic Value?
Jan 07Is Now The Time To Put Siegfried Holding (VTX:SFZN) On Your Watchlist?
Dec 02We Think Siegfried Holding (VTX:SFZN) Can Stay On Top Of Its Debt
Nov 13A Look At The Intrinsic Value Of Siegfried Holding AG (VTX:SFZN)
Sep 28Here's Why We Think Siegfried Holding (VTX:SFZN) Might Deserve Your Attention Today
Aug 16With EPS Growth And More, Siegfried Holding (VTX:SFZN) Makes An Interesting Case
May 13Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?
Apr 25With EPS Growth And More, Siegfried Holding (VTX:SFZN) Makes An Interesting Case
Jan 20Is Siegfried Holding (VTX:SFZN) A Risky Investment?
Dec 28Here's Why Siegfried Holding (VTX:SFZN) Has Caught The Eye Of Investors
Oct 13Siegfried Holding (VTX:SFZN) Has A Pretty Healthy Balance Sheet
Sep 25Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?
Jun 24Siegfried Holding (VTX:SFZN) Seems To Use Debt Quite Sensibly
Apr 08Do Siegfried Holding's (VTX:SFZN) Earnings Warrant Your Attention?
Mar 21Does Siegfried Holding (VTX:SFZN) Have A Healthy Balance Sheet?
Dec 23Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?
Dec 05Here's Why Siegfried Holding (VTX:SFZN) Can Manage Its Debt Responsibly
Sep 19If You Like EPS Growth Then Check Out Siegfried Holding (VTX:SFZN) Before It's Too Late
Sep 01These 4 Measures Indicate That Siegfried Holding (VTX:SFZN) Is Using Debt Reasonably Well
Jun 11Here's Why We Think Siegfried Holding (VTX:SFZN) Is Well Worth Watching
May 25Is Siegfried Holding (VTX:SFZN) A Risky Investment?
Mar 03Shareholders Are Thrilled That The Siegfried Holding (VTX:SFZN) Share Price Increased 227%
Jan 18Do Fundamentals Have Any Role To Play In Driving Siegfried Holding AG's (VTX:SFZN) Stock Up Recently?
Dec 22
What Kind Of Shareholders Hold The Majority In Siegfried Holding AG's (VTX:SFZN) Shares?
Nov 25Revenue & Expenses BreakdownBeta
How Siegfried Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,271 | 113 | 107 | 43 |
| 30 Sep 23 | 1,261 | 131 | 75 | 44 |
| 30 Jun 23 | 1,250 | 149 | 44 | 45 |
| 31 Mar 23 | 1,240 | 153 | 44 | 44 |
| 31 Dec 22 | 1,230 | 156 | 43 | 43 |
| 30 Sep 22 | 1,226 | 143 | 62 | 43 |
| 30 Jun 22 | 1,222 | 129 | 80 | 42 |
| 31 Mar 22 | 1,162 | 112 | 73 | 41 |
| 31 Dec 21 | 1,102 | 96 | 66 | 40 |
| 30 Sep 21 | 1,013 | 83 | 70 | 38 |
| 30 Jun 21 | 924 | 69 | 73 | 36 |
| 31 Mar 21 | 884 | 65 | 70 | 34 |
| 31 Dec 20 | 845 | 61 | 68 | 31 |
| 30 Sep 20 | 836 | 52 | 75 | 29 |
| 30 Jun 20 | 828 | 43 | 83 | 28 |
| 31 Mar 20 | 831 | 48 | 85 | 30 |
| 31 Dec 19 | 834 | 53 | 87 | 33 |
| 30 Sep 19 | 822 | 56 | 72 | 34 |
| 30 Jun 19 | 811 | 58 | 58 | 34 |
| 31 Mar 19 | 803 | 57 | 58 | 31 |
| 31 Dec 18 | 794 | 56 | 58 | 27 |
| 30 Sep 18 | 786 | 52 | 61 | 27 |
| 30 Jun 18 | 779 | 49 | 64 | 26 |
| 31 Mar 18 | 765 | 45 | 61 | 26 |
| 31 Dec 17 | 750 | 41 | 58 | 26 |
| 30 Sep 17 | 732 | 38 | 55 | 25 |
| 30 Jun 17 | 713 | 36 | 52 | 24 |
| 31 Mar 17 | 716 | 32 | 53 | 23 |
| 31 Dec 16 | 718 | 28 | 54 | 21 |
| 30 Sep 16 | 676 | 30 | 53 | 22 |
| 30 Jun 16 | 633 | 33 | 51 | 23 |
| 31 Mar 16 | 557 | 36 | 44 | 23 |
| 31 Dec 15 | 481 | 39 | 37 | 23 |
| 30 Sep 15 | 416 | 39 | 31 | 22 |
| 30 Jun 15 | 351 | 40 | 25 | 21 |
| 31 Mar 15 | 333 | 39 | 25 | 21 |
| 31 Dec 14 | 315 | 39 | 25 | 21 |
| 30 Sep 14 | 329 | 46 | 32 | 21 |
| 30 Jun 14 | 343 | 54 | 38 | 22 |
| 31 Mar 14 | 359 | 54 | 41 | 22 |
| 31 Dec 13 | 375 | 54 | 44 | 23 |
| 30 Sep 13 | 380 | 40 | 47 | 24 |
| 30 Jun 13 | 386 | 26 | 50 | 24 |
Quality Earnings: SFZN has high quality earnings.
Growing Profit Margin: SFZN's current net profit margins (8.9%) are lower than last year (12.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SFZN's earnings have grown significantly by 25.2% per year over the past 5 years.
Accelerating Growth: SFZN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SFZN had negative earnings growth (-28%) over the past year, making it difficult to compare to the Life Sciences industry average (-9.5%).
Return on Equity
High ROE: SFZN's Return on Equity (13.4%) is considered low.